Tomislav Preveden
Full Professor
Clinical Center of Vojvodine, Clinic for Infectious Diseases
tomislav.preveden@mf.uns.ac.rs
Phone: 0214843305
ORCID ID :
Clinical Center of Vojvodine, Clinic for Infectious Diseases
tomislav.preveden@mf.uns.ac.rs
Phone: 0214843305
ORCID ID :
| Academic career | Year | Institution | Field |
|---|---|---|---|
Status Acquired |
2022 |
Faculty of Medicine Novi Sad |
Infectious Diseases | PhD |
2012 |
Faculty of Medicine Novi Sad |
Infectious Diseases |
Specialization |
1993 |
Faculty of Medicine Novi Sad |
Infectious Diseases |
MSc |
1992 |
Faculty of Medicine Novi Sad |
Neuroendocrinology |
Graduated |
1987 |
Faculty of Medicine Novi Sad |
General Medicine |
| M | Description |
|---|---|
22 | Abenavoli L, Milic N, Di Renzo L, Preveden T, Medić-Stojanoska M, De Lorenzo A. Metabolic aspects of adult patients with nonalcoholic fatty liver disease. World J Gastroenterol 2016;22(31):7006-16 |
23 | Preveden T, Ružić M, Kovačević N, Pete M, Fabri. The occurrence of liver steatosis in patients with chronic hepatitis C - the experience of the Clinical Center of Vojvodina. Vojnosanit Pregl 2018;75(1):1070-5 |
23 | Ružić M, Fabri M, Preveden T, Bačulov K, Pete M, Stojšin A. Autoimmune manifestation of hepatitis C virus infection as a risk for late virological relapse after pegylated interferon and ribavirin therapy. Vojnosanit Pregl 2017. DOI: 10.2298/VSP161026015R Online First January, 2017. |
23 | Kovačević N, Doder R, Preveden T, Pete M. Risk factors for recurrent Clostridium difficile infection among patients in Clinical Centre of Vojvodina, Serbia: retrospective clinical trial Vojnosanit Pregl 2017 DOI: 10.2298/VSP170321119K Online First September, 2017 |
23 | Preveden T, Ružić M, Pete M. The influenze of hepatic steatosis on the succes of antiviral therapy for chronic hepatitis C. Vojnosanit Pregl 2016;74(4):317–322 |
23 | Fabri M, Ružić M, Lendak D, Preveden T, Fabri I, Petrić V. Extrahepatic manifestations of chronic hepatitis C and their influence on response to treatment with pegylated interferon alfa-2a and ribavirin. Srp Arh Celok Lek 2013;141(5-6):320-4 |
51 | Preveden T, Ruzic M, Lendak D, Pete M, Abenavoli L, Brkic S. Chronic Hepatitis C and Alcohol Abuse: The Single Center Experience of Novi Sad - Serbia. Rev Recent Clin Trials 2016;11(3):208-12 |
51 | Preveden T.Bacterial infections in patients with liver cirrhosis. Med Pregl 2015; 68(5-6):187-91 |
51 | Preveden T , Vujanović M.,Ružić M, Kovačević N, Doder R, Tomić S. Kliničko-epidemiološke karakteristike hroničnog hepatitisa C kod osoba starijeg životnog doba. Med Pregl 2014;LXVII(Suppl 2):39-43 |
51 | Preveden T , Vujanović M.,Ružić M, Kovačević N, Doder R, Tomić S. Kliničko-epidemiološke karakteristike hroničnog hepatitisa C kod osoba starijeg životnog doba. Med Pregl 2014;LXVII(Suppl 2):39-43 |
| Course | Studies |
|---|---|
Infectious Diseases | Integrated academic studies in medicine |
Infectious Diseases | Integrated academic studies in dentistry |
Nursing care of infectious patients and infectious diseases | Undergraduate academic studies in nursing |
Nursing care of infectious patients and infectious diseases | Undergraduate applied studies in nursing |